Today, Explained

What Ozempic can't fix

33 snips
Feb 26, 2024
Alice Fullwood, an economics writer at The Economist, and Kate Mann, an associate professor at Cornell, dive into the harsh realities of fatphobia in America. They discuss how fat women earn less than their thinner counterparts and face obstacles in promotions. The conversation critiques the societal pressure for weight loss linked to economic and career opportunities. They evaluate the efficacy of weight-loss drugs like Ozempic, revealing that economic success goes beyond mere body transformation and challenges deep-rooted biases in health and employment.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Economics of Thinness

  • Thin women face fewer economic penalties than larger women, impacting their income and career progression.
  • This disparity is evident globally, particularly in developed countries, affecting women across various careers and income levels.
ANECDOTE

The CDC Chart

  • Fullwood Alice's husband showed her a CDC chart illustrating the inverse relationship between BMI and income for women.
  • This sparked her realization of the economic incentives tied to thinness for women.
INSIGHT

Subtle Awareness

  • Women are subtly aware of the economic advantages of thinness, influencing their choices in wellness and appearance.
  • This awareness manifests in the language used to justify expensive fitness activities as "investments."
Get the Snipd Podcast app to discover more snips from this episode
Get the app